Animal vaccine market was valued at $13.5 billion in 2024 and is projected to reach $38.7 billion by 2035, growing at a CAGR of 10.1% during the forecast period (2025-2035). The growth of the global animal vaccine market is driven by increasing demand for livestock and poultry products across developed and emerging economies. Higher consumption of meat, dairy, eggs, and aquaculture products has led producers to place greater emphasis on animal health management to maintain production levels and reduce disease-related losses. Vaccination is used as a preventive measure to control disease outbreaks, improve herd health, and support the continuity of food supply chains. As commercial farming systems expand, routine immunization practices are being adopted across cattle, poultry, swine, and aquaculture segments.
Browse the full report description of “Animal Vaccine Market Size, Share & Trends Analysis by Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines), and by Technology (Live Attenuated Vaccines, Killed/Inactivated Vaccine, Recombinant Vaccines, and Other) Forecast Period (2025-2035)” of https://www.omrglobal.com/industry-reports/animal-vaccine-market
Another factor influencing market growth is the prevalence of infectious and transboundary animal diseases that affect livestock health and food security. According to the World Organisation for Animal Health (WOAH), more than 60% of known infectious diseases in humans are of animal origin, and over 75% of emerging infectious diseases are zoonotic. This has increased the implementation of vaccination programs aimed at reducing disease transmission between animal populations and humans. Vaccines are used for the management of diseases such as foot-and-mouth disease, avian influenza, and classical swine fever across multiple livestock categories.
The scale of global livestock populations and limitations in vaccination coverage also contribute to market expansion. Data published by the Food and Agriculture Organization (FAO) indicate that the global poultry population exceeds 27 billion birds, while cattle and pig populations are approximately 1.57 billion and 778 million, respectively. However, vaccination coverage remains uneven across regions. Published studies indicate that less than 17% of cattle at risk are vaccinated against foot-and-mouth disease and under 7% of pigs are vaccinated against classical swine fever. These conditions are associated with continued demand for veterinary vaccines and expansion of immunization programs.
Key Innovators Driving Animal Vaccine Market Advancement
The key players in the global animal vaccine market include Boehringer Ingelheim International GmbH, Ceva Santé Animale, Elanco Animal Health Inc., Merck Animal Health, and Zoetis Inc., among others. These companies are engaged in the development and commercialization of veterinary vaccines for livestock and companion animals. Their activities focus on expanding disease coverage, improving vaccine efficacy, and supporting large-scale immunization programs to control infectious animal diseases.
Market Coverage
Key questions addressed by the report.
Animal vaccine market Report Segment
By Type
By Technology
Animal vaccine market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/animal-vaccine-market